« Return to search form

Violation Tracker Parent Company Summary

Parent Company Name: 
Bristol-Myers Squibb
Ownership Structure: 
publicly traded (ticker symbol BMY)
Headquartered in: 
New York
Major Industry: 
pharmaceuticals
Specific Industry: 
pharmaceuticals
Penalty total since 2000: 
$1,554,891,420
Number of records: 
34
Top 5 Offense Groups (Groups Defined)Penalty TotalNumber of Records
healthcare-related offenses$534,500,0003
competition-related offenses$500,116,2007
government-contracting-related offenses$320,338,7195
financial offenses$150,006,6002
employment-related offenses$41,380,2032
Top 5 Primary Offense TypesPenalty TotalNumber of Records
off-label or unapproved promotion of medical products$534,500,0003
False Claims Act and related$320,338,7195
fraud$300,000,0001
price-fixing or anti-competitive practices$156,100,0003
accounting fraud or deficiencies$150,000,0001
Notes: 

Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.

Associated Names: 

American Pharmaceutical Partners, Inc.; BRISTOL MYERS SQUIBB; BRISTOL MYERS SQUIBB MEDICAL IMAGING; BRISTOL MYERS SQUIBB MFG; Bristol-Myers Squibb Company and Apothecon, Inc.; Briston-Myers Squibb; CELGENE; DUPONT PHARMACEUTICALS; ER SQUIBB AND SONS; Global Strategic Partners LLC

Links: 

Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.

For an overview of assistance this company is receiving under the CARES Act, see its Covid Stimulus Watch summary page here.


Individual Penalty Records:

Click on the company or penalty amount for more information on each case.
Download results as CSV or XML (maximum 10,000; for access to larger downloads contact Phil Mattera)
Company Primary Offense Type Year Agency Penalty Amountsort icon
BRISTOL-MYERS SQUIBB COMPANY environmental violation 2000 EPA $5,000
E.R. SQUIBB & SONS, LLC. environmental violation 2013 EPA $5,950
Celgene Corporation environmental violation 2013 EPA $6,035
DuPont Pharmaceuticals Company economic sanction violation 2004 OFAC $6,600
BRISTOL-MYERS SQUIBB CO environmental violation 2001 EPA $7,600
E.R. Squibb & Sons LLC environmental violation 2009 EPA $8,125
Global Strategic Partners LLC motor vehicle safety violation 2015 FMCSA $8,680
Bristol-Myers Squibb Medical Imaging, Inc. export control violation 2004 BIS $16,200
BRISTOL - MYERS SQUIBB MEDICAL IMAGING INC environmental violation 2009 EPA $19,538
BRISTOL-MYERS SQUIBB CO environmental violation 2011 EPA $20,000
Bristol Myers Squibb Manufacturing Company environmental violation 2008 EPA $52,000
Bristol Myers Squibb Company environmental violation 2008 EPA $66,770
American Pharmaceutical Partners, Inc. wage and hour violation 2004 WHD $160,203
Bristol-Myers Squibb drug or medical equipment safety violation 2007 DOJ_ANTITRUST $1,000,000
Bristol-Myers Squibb Company price-fixing or anti-competitive practices 2008 MULTI-AG $1,100,000
Bristol-Myers Squibb Company consumer protection violation 2019 WV-AG $1,600,000
Bristol-Myers Squibb Company and Apothecon, Inc. False Claims Act and related 2008 ID-AG $1,738,719
Bristol-Myers Squibb Company consumer protection violation 2009 FTC $2,100,000
Bristol-Myers Squibb environmental violation 2009 EPA (*) $2,328,154
Bristol-Myers Squibb environmental violation 2008 EPA $3,650,000
Bristol-Myers Squibb False Claims Act and related 2008 AL-AG $11,000,000
Bristol-Myers Squibb Foreign Corrupt Practices Act 2015 SEC $14,000,000
Bristol-Myers Squibb off-label or unapproved promotion of medical products 2016 MULTI-AG $19,500,000
Celgene Corp. off-label or unapproved promotion of medical products 2017 MULTI-AG (*) $20,700,000
Bristol-Myers Squibb False Claims Act and related 2010 PA-AG $27,600,000
Bristol-Myers Squibb kickbacks and bribery 2016 CA-INS $30,000,000
Briston-Myers Squibb benefit plan administrator violation 2005 private lawsuit-federal $41,220,000
Bristol-Myers Squibb price-fixing or anti-competitive practices 2003 MULTI-AG $55,000,000
Bristol-Myers Squibb Co. price-fixing or anti-competitive practices 2003 MULTI-AG $100,000,000
Bristol-Myers Squibb Company accounting fraud or deficiencies 2004 SEC $150,000,000
Bristol-Myers Squibb False Claims Act and related 2008 MULTI-AG (*) $187,000,000
Celgene Corp. False Claims Act and related 2017 USAO $280,000,000
Bristol-Myers Squibb fraud 2005 USAO $300,000,000
Bristol-Myers Squibb Company off-label or unapproved promotion of medical products 2007 DOJ_CIVIL $515,000,000
Download results as CSV or XML (maximum 10,000; for access to larger downloads contact Phil Mattera)